The WISDOM study: a new approach to screening can and should be tested-Reference-Cited by-同舟云学术

The WISDOM study: a new approach to screening can and should be tested

Published:2021-09-16 Issue:3 Volume:189 Page:593-598
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Esserman Laura^ORCID,Eklund Martin,Veer Laura van’t,Shieh Yiwey,Tice Jeffrey,Ziv Elad,Blanco Amie,Kaplan Celia,Hiatt Robert,Fiscalini Allison Stover,Yau Christina,Scheuner Maren,Naeim Arash,Wenger Neil,Lee Vivian,Heditsian Diane,Brain Susie,Parker Barbara A.,LaCroix Andrea Z.,Madlensky Lisa,Hogarth Michael,Borowsky Alexander,Anton-Culver Hoda,Kaster Andrea,Olopade Olufunmilayo I.,Sheth Deepa,Garcia Augustin,Lancaster Rachael,Plaza Michael

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

https://link.springer.com/content/pdf/10.1007/s10549-021-06346-w.pdf

Reference34 articles.

1. Shieh Y, Eklund M, Madlensky L et al (2017) Breast cancer screening in the precision medicine era: risk-based screening in a population-based trial. J National Cancer Inst 109(5):djw290. https://doi.org/10.1093/jnci/djw290

2. Esserman LJ (2017) The WISDOM Study: breaking the deadlock in the breast cancer screening debate. NPJ Breast Cancer 3(1):34. https://doi.org/10.1038/s41523-017-0035-5

3. Eklund M, Broglio K, Yau C, Connor JT, Fiscalini AS, Esserman LJ (2018) The WISDOM personalized breast cancer screening trial: simulation study to assess potential bias and analytic approaches. JNCI Cancer Spectr 2(4):279. https://doi.org/10.1093/jncics/pky067

4. Consortium IST, Yee D, DeMichele AM et al (2020) Association of event-free and distant recurrence-free survival with individual-level pathologic complete response in neoadjuvant treatment of stages 2 and 3 breast cancer. JAMA Oncol 6(9):1355–1362. https://doi.org/10.1001/jamaoncol.2020.2535

5. Rugo HS, Olopade OI, DeMichele A et al (2016) Adaptive randomization of veliparib-carboplatin treatment in breast cancer. N Engl J Med 375(1):23–34. https://doi.org/10.1056/nejmoa1513749

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Women’s experiences of risk-stratified breast cancer screening in the MyPeBS trial: a qualitative comparative study across two European countries;Psychology & Health;2024-09-02

2. Limited impact of adding digital breast tomosynthesis to full field digital mammography in an elevated breast cancer risk population;European Journal of Radiology;2024-08

3. ESR Essentials: screening for breast cancer - general recommendations by EUSOBI;European Radiology;2024-04-24

4. Implementation considerations for risk-tailored cancer screening in the population: A scoping review;Preventive Medicine;2024-04

5. The risk-based breast screening (RIBBS) study protocol: a personalized screening model for young women;La radiologia medica;2024-03-21